Corporate Report

The report describes Ono's FY2024 value-creation story, centered on the acquisition of Deciphera and the acceleration of its evolution into a Global Specialty Pharma. It explains the reorganization of 18 materialities into nine and expands discussion of human, intellectual and social relationship capital. Environmental highlights include a 70.3% Scope 1 + 2 reduction from FY2017 and 93.2% renewable electricity utilization, while the report also details human-rights, supply-chain and diversity initiatives.